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Weappreciate the interest and comments fromDr. Shi-
Ying Xuan and colleagues and Dr. Huang Ching-I and
colleagues regarding our paper [1]. The issues they have
raised are highly relevant. Although the sensitivity of
commercial HBsAg assays needs to be improved, the clin-
ical relevance of positivity for low HBsAg has not been
clariﬁed. Our study demonstrated that infection with
HBV, including occult HBV, is far more prevalent than
previously thought, as a result of increasing the sensitivity
of HBsAg detection to below the present limit [1].
Occult HBV infection has been considered to be
transmitted via blood transfusion and tissue or organ
transplantation [2]. However, as details of the infection
routes and involvement of occult HBV in liver diseases
have been obscure, establishment of a convenient
screening method for occult HBV infection will inevita-
bly be required. Although occult HBV infection may be
clinically inoﬀensive in itself, when other important
causes of liver damage co-exist, the minimal lesions pro-
duced by the immune response to the occult virus might
contribute to exacerbating the course of the liver disease
over time [2]. If this is indeed the case, then the low-level
HBV viraemia we have demonstrated could be clinically
relevant. We believe that radical immunoassay measure-
ment for HBsAg is one convenient option for the screen-
ing of occult HBV infection. The radical immunoassay
should make it possible to perform scientiﬁcally valid
epidemiological surveys of occult HBV infection status
and its pathologic role in areas where HBV infection is
endemic should be performed scientiﬁcally. Science
based investigations never cause unnecessary unease in
the community.
We consider it unrealistic to detect HBV DNA in the
liver tissues along the lines suggested byDr.Xuan and col-
leagues from the viewpoint of invasiveness and speciﬁcity.
It might be better to reconﬁrm false negativity for anti-
HBc using more sensitive anti-HBc measurements as
Dr. Huang and colleagues suggested; however anti-HBc
measurements are not superior because of their presumed
non-speciﬁcity. In addition to being highly sensitive, the
radical immunoassay method has both satisfactory with-
in-run and run-to-run reproducibility is satisfactory, as
we have reported previously [3]. We consider that radical
immunoassaymethod for themeasurement ofHBsAg is a
practically useful analytical procedure in view of its low
cost, rapidity, and simplicity.Radical immunoassay method for the detection of low
HBsAg in combination with real-time PCR detection of
HBVDNA is a promising new approach for screening oc-
cult HBV carriers among healthy subjects and patients
with various liver diseases. As Dr. Xuan and colleagues
andDr. Huang and colleagues point out, an important is-
sue is how to deal with individuals who have low HBsAg
positivity withoutHBVDNA.Of course, we cannot diag-
nose HBV carriers based solely on low HBsAg positivity
using the radical immunoassay method. We speculate
that the presence of some cases showing low HBsAg but
negativity for HBVDNAmight reﬂect the process of nat-
ural clearance ofHBsAgor integration of the surface gene
into hepatocytes without the core gene. To further clarify
these issues, we are planning two projects. Firstly, we in-
tend to follow up the changes in low HBsAg concentra-
tion and the appearance of HBV DNA in cancer
patients who have a low HBsAg concentration and
HBV DNA negativity after anti-cancer chemotherapy.
Secondly, we intend to survey the status of occult HBV
infection in a country where HBV infection is more ende-
mic than in Japan. We are grateful to Dr. Xuan and col-
leagues and Dr. Huang and colleagues for their
thoughtful comments.
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